Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors.
作者信息
Shinozaki Satoshi, Osawa Hiroyuki, Hayashi Yoshikazu, Sakamoto Hirotsugu, Miura Yoshimasa, Lefor Alan Kawarai, Yamamoto Hironori
机构信息
Shinozaki Medical Clinic, Utsunomiya, Japan.
Division of Gastroenterology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
出版信息
Singapore Med J. 2022 May;63(5):283-287. doi: 10.11622/smedj.2022076.
Abstract
摘要
相似文献
1
Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors.与质子泵抑制剂相比，长期使用沃克唑胺期间胃形态的变化。
Singapore Med J. 2022 May;63(5):283-287. doi: 10.11622/smedj.2022076.
2
Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis.10mg 沃诺拉赞长期维持治疗质子泵抑制剂抵抗性反流性食管炎的疗效。
Esophagus. 2019 Oct;16(4):377-381. doi: 10.1007/s10388-019-00676-x. Epub 2019 May 22.
3
Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study.新型钾离子竞争性酸阻滞剂沃诺拉赞是否比传统质子泵抑制剂引起更多的高胃泌素血症？一项多中心前瞻性横断面研究。
Digestion. 2018;97(1):70-75. doi: 10.1159/000484217. Epub 2018 Feb 1.
4
Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.vonoprazan 在胃内镜黏膜下剥离术后人工溃疡愈合方面优于质子泵抑制剂：倾向评分匹配分析。
Dig Endosc. 2017 Jan;29(1):57-64. doi: 10.1111/den.12705. Epub 2016 Sep 5.
5
The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.换用新型钾离子竞争性酸阻滞剂沃克瑞对质子泵抑制剂难治性糜烂性食管炎患者胃酸分泌及反流模式的影响
Digestion. 2017;96(1):52-59. doi: 10.1159/000478255. Epub 2017 Jun 30.
6
Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.内镜黏膜下剥离术后治疗人工胃溃疡：Vonoprazan 与兰索拉唑的随机、开放标签试验。
BMC Gastroenterol. 2021 May 22;21(1):236. doi: 10.1186/s12876-021-01822-5.
7
Efficacy of Vonoprazan for Helicobacter pylori Eradication.沃克帕唑用于根除幽门螺杆菌的疗效。
Intern Med. 2020 Jan 15;59(2):153-161. doi: 10.2169/internalmedicine.2521-18. Epub 2019 Jun 27.
8
Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers.质子泵抑制剂（埃索美拉唑和沃诺拉赞）对环丙沙星（CYP2C19 底物）在健康志愿者体内处置的影响。
Br J Clin Pharmacol. 2019 Jul;85(7):1454-1463. doi: 10.1111/bcp.13914. Epub 2019 Apr 16.
9
Vonoprazan-associated Gastric Mucosal Redness: A Report of Four Cases.沃克帕唑相关的胃黏膜发红：4例报告
Intern Med. 2020 Feb 15;59(4):507-511. doi: 10.2169/internalmedicine.3715-19. Epub 2019 Oct 15.
10
The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.比较 vonoprazan 与质子泵抑制剂治疗内镜黏膜下剥离术后溃疡的疗效：一项荟萃分析。
J Dig Dis. 2019 Oct;20(10):503-511. doi: 10.1111/1751-2980.12813. Epub 2019 Sep 30.
引用本文的文献
1
[Type A, Type B, and Non-atrophic Gastritis].[A 型、B 型和非萎缩性胃炎]
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):108-117. doi: 10.7704/kjhugr.2023.0015. Epub 2023 Jun 12.
2
Current research status and trends of potassium-competitive acid blockers in the treatment of acid-related diseases: a bibliometric analysis.钾离子竞争性酸阻滞剂治疗酸相关性疾病的研究现状与趋势：一项文献计量学分析
Front Pharmacol. 2025 Jan 7;15:1477633. doi: 10.3389/fphar.2024.1477633. eCollection 2024.
3
Endoscopic findings and outcomes of gastric mucosal changes relating to potassium-competitive acid blocker and proton pump inhibitor therapy.与钾离子竞争性酸阻滞剂和质子泵抑制剂治疗相关的胃黏膜变化的内镜检查结果及转归
DEN Open. 2024 Jun 24;5(1):e400. doi: 10.1002/deo2.400. eCollection 2025 Apr.
4
Drug-induced mucosal alterations observed during esophagogastroduodenoscopy.食管胃十二指肠镜检查中观察到的药物引起的黏膜改变。
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.
5
Potassium-competitive acid blocker-associated gastric mucosal lesions.钾离子竞争性酸阻滞剂相关胃黏膜病变
Clin Endosc. 2024 Jul;57(4):417-423. doi: 10.5946/ce.2023.279. Epub 2024 Feb 29.
6
The Impact of Sex on the Response to Proton Pump Inhibitor Treatment.性别对质子泵抑制剂治疗反应的影响
Pharmaceuticals (Basel). 2023 Dec 12;16(12):1722. doi: 10.3390/ph16121722.
7
The effect of proton pump inhibitors and vonoprazan on the development of 'gastric mucosal redness'.质子泵抑制剂和沃克（富马酸伏诺拉生）对“胃黏膜发红”发展的影响。
Biomed Rep. 2022 Jun;16(6):51. doi: 10.3892/br.2022.1534. Epub 2022 May 6.
本文引用的文献
1
Current Status of Helicobacter pylori Diagnosis and Eradication Therapy in Japan Using a Nationwide Database.日本使用全国性数据库进行的幽门螺杆菌诊断和根除治疗的现状。
Digestion. 2020;101(4):441-449. doi: 10.1159/000500819. Epub 2019 Jun 19.
2
Magnified Endoscopic Findings of Multiple White Flat Lesions: A New Subtype of Gastric Hyperplastic Polyps in the Stomach.多发白色扁平病变的放大内镜表现：胃内胃增生性息肉的一种新亚型
Clin Endosc. 2018 Nov;51(6):558-562. doi: 10.5946/ce.2018.104. Epub 2018 Nov 21.
3
Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.使用沃克奥美拉唑治疗的有症状胃食管反流病患者的长期结局
Scand J Gastroenterol. 2018 Aug;53(8):897-904. doi: 10.1080/00365521.2018.1486883. Epub 2018 Jul 28.
4
Multiple White and Flat Elevated Lesions Observed in the Stomach: A Prospective Study of Clinical Characteristics and Risk Factors.胃内观察到多个白色扁平隆起性病变：临床特征及危险因素的前瞻性研究
Intern Med. 2018 Sep 15;57(18):2613-2619. doi: 10.2169/internalmedicine.9889-17. Epub 2018 Apr 27.
5
Prevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup.接受体检者中多发白色扁平隆起性病变的患病率。
Intern Med. 2018 May 1;57(9):1213-1218. doi: 10.2169/internalmedicine.9808-17. Epub 2017 Dec 27.
6
Proton-pump inhibitors: understanding the complications and risks.质子泵抑制剂：了解其并发症和风险。
Nat Rev Gastroenterol Hepatol. 2017 Dec;14(12):697-710. doi: 10.1038/nrgastro.2017.117. Epub 2017 Sep 20.
7
Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.质子泵抑制剂诱发胃内鹅卵石样病变
Intern Med. 2017 Oct 15;56(20):2699-2703. doi: 10.2169/internalmedicine.7964-16. Epub 2017 Sep 15.
8
Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study.长期使用质子泵抑制剂期间胃黏膜的内镜检查结果——一项多中心研究
Scand J Gastroenterol. 2017 Aug;52(8):828-832. doi: 10.1080/00365521.2017.1322137. Epub 2017 May 9.
9
Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.使用质子泵抑制剂导致胃黏膜出现裂纹和鹅卵石样改变。
Dig Endosc. 2017 May;29(3):307-313. doi: 10.1111/den.12765. Epub 2017 Jan 22.
10
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
Zotero 插件